For decades, China’s dominance in Active Pharmaceutical Ingredient (API) manufacturing looked unassailable. Low-cost production and massive scale made it the default choice for global procurement teams. But geopolitical tensions, pandemic-era […]
Archive for April, 2026
Blogs
The 2026 Strategic CDMO Shift Bridging the R&D Scale-Up Gap
By SEO Support
- April 2, 2026
In the 2026 pharmaceutical sector, the traditional, highly transactional vendor-buyer relationship has become obsolete. As global demand for specialized small-molecule synthesis accelerates, the industry is transitioning toward deeply collaborative Contract […]